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Background: . The Global Registry of Acute Coronary Events (GRACE) risk score was developed in a large multinational registry to predict 6-month 
post-discharge mortality across the broad spectrum of acute coronary syndromes (ACS). Because of the substantial regional variation in patient 
characteristics and management patterns, we sought to validate this risk score in a contemporary Spain population with ACS managed with high rate 
of coronary revascularization procedures.
Methods: From February 2004 to February 2009, 1183 consecutive patients with ACS were prospectively included. The model’s validity was 
assessed on the basis of its calibration (using the Hosmer-Lemeshow test) and its discrimination (determining the area under the ROC curve).
Results: 459 (38.8%) patients presented with ST-elevation acute myocardial infarction (STEMI) and 724 (61.2%) with ACS without ST segment 
elevation. Percutaneous revascularization was performed in 846 (71.5%). The median GRACE risk score was of 121 [96-144] points. The 6-month 
postdischarge death was of 4.4%. In the whole population, in the group of patients with STEMI and in those presented with ACS without ST segment 
elevation, the GRACE risk score showed adequate calibration and excellent discrimination [Hosmer-Lemeshow test: p >0.2 (x2 <10), and area 
under the ROC curve of 0.86 (CI 95% [0.807-0.916]), 0.90 [0.829-0. 975]) and of 0.86 [0.783-0.927]; respectively. In the groups with and without 
percutaneous coronary revascularization during the index hospitalization, the model was also validated adequately (Hosmer-Lemeshow p >0.1 
(x2<5), and area under the ROC curve of 0.84 (0.748-0.922) and of 0.91 (0.863 -0.948), respectively).
Conclusion: GRACE risk score is a valid and powerful predictor of 6-month mortality across a wide range of Spanish patients with ACS. In our 
setting, is useful to include this risk score in the daily care of these patients.
